Literature DB >> 34676032

Substituted 2,3-Benzodiazepines Derivatives as Bromodomain BRD4 Inhibitors.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID: 34676032      PMCID: PMC8521623          DOI: 10.1021/acsmedchemlett.1c00487

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Bromodomain-containing protein 4 and its role in cardiovascular diseases.

Authors:  Liang Li; Wei Xie; Yu Gui; Xi-Long Zheng
Journal:  J Cell Physiol       Date:  2020-12-20       Impact factor: 6.384

2.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

Review 3.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

Review 4.  BRD4: An emerging prospective therapeutic target in glioma.

Authors:  Hua Yang; Li Wei; Yang Xun; Anping Yang; Hua You
Journal:  Mol Ther Oncolytics       Date:  2021-03-05       Impact factor: 7.200

Review 5.  Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?

Authors:  Thanarat Salahong; Christian Schwartz; Rungroch Sungthong
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

Review 6.  Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.

Authors:  Ewelina Kulikowski; Brooke D Rakai; Norman C W Wong
Journal:  Med Res Rev       Date:  2020-09-14       Impact factor: 12.944

  6 in total
  3 in total

1.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

2.  Virtual Special Issue: Epigenetics 2022.

Authors:  Courtney C Aldrich; Félix Calderón; Stuart J Conway; Chuan He; Jacob M Hooker; Donna M Huryn; Craig W Lindsley; Dennis C Liotta; Christa E Müller
Journal:  ACS Med Chem Lett       Date:  2022-10-13       Impact factor: 4.632

3.  Linker-Dependent Folding Rationalizes PROTAC Cell Permeability.

Authors:  Vasanthanathan Poongavanam; Yoseph Atilaw; Stephan Siegel; Anja Giese; Lutz Lehmann; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  J Med Chem       Date:  2022-09-28       Impact factor: 8.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.